TAM
VAXX

Titleist Asset Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Titleist Asset Management’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27,649
Closed -$19.8K – 277
2024
Q1 		$19.8K Hold
27,649
– – ﹤0.01% 252
2023
Q4 		$23.5K Hold
27,649
– – ﹤0.01% 219
2023
Q3 		$37.9K Hold
27,649
– – 0.01% 211
2023
Q2 		$69.7K Buy
+27,649
New +$58.6K 0.01% 215

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Titleist Asset Management's VAXX Position: Q2 2024 in Review

Titleist Asset Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 27,649 shares — an estimated $19.8K sold.

Titleist Asset Management first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $69.7K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Titleist Asset Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Titleist Asset Management sold 27,649 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $19.8K.
  • Titleist Asset Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
  • Titleist Asset Management's Vaxxinity, Inc. Class A Common Stock position peaked at $69.7K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Titleist Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.